Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.23 +0.28 (+1.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Operating Expenses (2020 - 2026)

Updated

Cullinan Therapeutics (CGEM) reported Operating Expenses of $57.25 million for Q2 2026, down 24.5% from $75.8 million a year earlier but up 6.6% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Operating Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cullinan Therapeutics' Operating Expenses came in at $221.81 million, down 5.5% year-over-year; for FY2025, it came in at $241.65 million, up 22.7% from FY2024.

  • Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 32.0% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $196.92 million in FY2024 (+3.3%), $190.65 million in FY2023 (+44.3%), $132.14 million in FY2022 (+52.1%) and $86.9 million in FY2021 (+44.0%).
  • Five-year quarterly Operating Expenses spans a low of $18.38 million in Q3 2021 and a high of $75.8 million in Q2 2025.
  • Year over year, Operating Expenses gained in six of the last eight quarters, with growth averaging 12.1%.
  • The high point for year-over-year Operating Expenses in five years was Q2 2022 (growth of 123.5%); the low point was Q1 2024 (a decline of 31.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $53.7 million (Q1 2026), $55.26 million (Q4 2025) and $55.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn - 57.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.25 Mn
Mar 31, 2026 53.70 Mn
Dec 31, 2025 55.26 Mn
Sep 30, 2025 55.60 Mn
Jun 30, 2025 75.80 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 55.05 Mn
Sep 30, 2024 48.86 Mn
Jun 30, 2024 50.03 Mn
Mar 31, 2024 42.99 Mn
Dec 31, 2023 45.49 Mn
Sep 30, 2023 44.80 Mn
Jun 30, 2023 37.61 Mn
Mar 31, 2023 62.76 Mn
Dec 31, 2022 32.61 Mn
Sep 30, 2022 29.77 Mn
Jun 30, 2022 37.11 Mn
Mar 31, 2022 32.66 Mn
Dec 31, 2021 34.35 Mn
Sep 30, 2021 18.38 Mn
API Access

Cullinan Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CGEM&period=max&api_key=YOUR_API_KEY